<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    FibroGen, Inc

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About FibroGen, Inc

    FibroGen, Inc. is a leading science-based biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics. The company applies its pioneering expertise in fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Thomas B. Neff
    • FOUNDED
      1993
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    MediWound Ltd.

    MediWound Ltd.

    MediWound is a fully integrated biopharmaceutical company focused on developing, m...

    MediWound is a fully integrated biopharmaceutic...

    Filing Type:    PU
    Interpace Diagnostics Group, Inc.

    Interpace Diagnostics Group, Inc.

    Interpace Diagnostics is focused on developing and commercializing molecular diagn...

    Interpace Diagnostics is focused on developing ...

    Filing Type:    PU
    Merit Medical Systems, Inc.

    Merit Medical Systems, Inc.

    Founded in 1987, Merit Medical set out to build the world’s most customer-focuse...

    Founded in 1987, Merit Medical set out to build...

    Filing Type:    PU
    MYOS RENS Technology Inc.

    MYOS RENS Technology Inc.

    MYOS RENS Technology, Inc. (NASDAQ: MYOS), a company based in Cedar Knolls, NJ was...

    MYOS RENS Technology, Inc. (NASDAQ: MYOS), a co...

    Filing Type:    PU
    Alterity Therapeutics Limited

    Alterity Therapeutics Limited

    We exist to create an alternate future for people living with neurodegenerative di...

    We exist to create an alternate future for peop...

    Filing Type:    PU
    Vaccinex, Inc.

    Vaccinex, Inc.

    Vaccinex is a clinical-stage biotechnology company engaged in the discovery and de...

    Vaccinex is a clinical-stage biotechnology comp...

    Filing Type:    PU
    Ourotech, Inc.

    Ourotech, Inc.

    A patient that is diagnosed with cancer today will have a genetic screen on their ...

    A patient that is diagnosed with cancer today w...

    Fundraising Status:    SD
    Filing Type:    CF
    Salarius Pharmaceuticals, Inc.

    Salarius Pharmaceuticals, Inc.

    Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company targeting the ...

    Salarius Pharmaceuticals, Inc. is a clinical-st...

    Filing Type:    PU
    MediciNova, Inc.

    MediciNova, Inc.

    MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiri...

    MediciNova, Inc. is a publicly-traded biopharma...

    Filing Type:    PU
    AMAG Pharmaceuticals, Inc.

    AMAG Pharmaceuticals, Inc.

    Headquartered in Waltham, Massachusetts, we develop and deliver innovative medicin...

    Headquartered in Waltham, Massachusetts, we dev...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.